13FPulse
中
AN

ANIX ANIXA BIOSCIENCES INC

2026Q2 · CUSIP 03528H109 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
62
Institutions that reported holding it to the SEC
Net increase in holders
+2
Last quarter 60 → now 62
How unusual is that
Below average
Stronger than only 45% of US stocks
What the filings say, in one paragraph

62 funds held ANIX at the end of 2026Q2, up 2 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, return on equity is -69.3%. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2018Q4: holders=16 2019Q1: holders=17 2019Q2: holders=16 2019Q3: holders=17 2019Q4: holders=17 2020Q1: holders=17 2020Q2: holders=19 2020Q3: holders=21 2020Q4: holders=22 2021Q1: holders=28 2021Q2: holders=32 2021Q3: holders=35 2021Q4: holders=41 2022Q1: holders=40 2022Q2: holders=44 2022Q3: holders=39 2022Q4: holders=47 2023Q1: holders=42 2023Q2: holders=44 2023Q3: holders=48 2023Q4: holders=54 2024Q1: holders=57 2024Q2: holders=52 2024Q3: holders=57 2024Q4: holders=56 2025Q1: holders=57 2025Q2: holders=64 2025Q3: holders=66 2025Q4: holders=70 2026Q1: holders=60 2026Q2: holders=62 -15 -7.5 +0 +7.5 +15 144474 18Q419Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush

This stock has never had a buying rush

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
35
Change in large funds
+3
Total value they hold
$15M
Funds buying for the first time
11
Funds that sold out entirely
9
Price change that quarter
—
Funds holding puts (bearish)
0
Funds holding calls (bullish)
2

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.30
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-69.3%
Debt ratio
11.0%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2024-01-31: EPS -0.10 2024-04-30: EPS -0.10 2024-07-31: EPS -0.10 2024-10-31: EPS -0.09 2025-01-31: EPS -0.10 2025-04-30: EPS -0.09 2025-07-31: EPS -0.07 2025-10-31: EPS -0.08 2026-01-31: EPS -0.08 2026-04-30: EPS -0.07 -0.11 -0.06 0.00 20242025202604/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-2M-965K0K 2016201720182019202020222023202420252026
Latest quarter $-1M (2020-10-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-04-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.